13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2018. See the latest, Q2 2026 →
Reported value
$366.12B
+4.2% on the quarter before
Positions
440
34 new · 37 sold out
Top 10
26.6%
of the value
Est. gain
+$14.64B
on stocks held all quarter
Est. return
+4.6%
on those stocks since Q1 2018
Positions as of Jun 30, 2018, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2018. Striped tiles are options.
Largest buys
Since Q1 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$3.97BAdded · 0.7% → 1.9%+20,406,462 shares
- Qualcomm~$1.74BAdded · 0.4% → 0.8%+31,068,827 shares
- Broadcom~$1.19BAdded · 1.2% → 1.5%+4,920,598 shares
- Altria Group Inc~$1.19BAdded · 1.0% → 1.2%+20,894,458 shares
- Exxon Mobil Corp~$1.12BAdded · 0.9% → 1.2%+13,483,489 shares
- Abbott Laboratories~$1.10BAdded · 1.9% → 2.2%+18,000,566 shares
- Diamondback Energy Inc~$1.02BNew · 0.0% → 0.3%+7,748,206 shares
- Gilead Sciences Inc~$998.4MAdded · 0.9% → 1.1%+14,093,328 shares
- Eog Resources Inc~$943.4MAdded · 1.3% → 1.7%+7,581,875 shares
- Cbs Corp Cl B N/V~$881.2MAdded · 0.1% → 0.4%+15,673,683 shares
Largest sells
Since Q1 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twenty-First Century Fox Inc Cl A (Limited Voting)~$2.62BCut · 1.1% → 0.7%−52,756,998 shares
- Amazon~$2.20BCut · 3.3% → 3.2%−1,296,737 shares
- Netflix~$1.47BCut · 3.5% → 4.0%−3,765,707 shares
- Verizon Communications Inc~$1.10BCut · 1.9% → 1.7%−21,846,302 shares
- Csx Corp~$991.2MCut · 1.4% → 1.3%−15,541,456 shares
- Stryker Corp~$975.6MCut · 1.3% → 1.1%−5,777,611 shares
- General Electric Co~$950.6MCut · 0.8% → 0.5%−69,846,101 shares
- Alibaba~$883.8MCut · 1.3% → 1.0%−4,763,416 shares
- Kellogg Co~$679.7MCut · 0.4% → 0.2%−9,728,732 shares
- Progressive Corp~$632.8MCut · 0.3% → 0.1%−10,698,846 shares
Holdings
As of Jun 30, 2018. Changes are in shares against Mar 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie IncCOMMON STOCK · shares +0.4% · price −2.1% | 4.9% | $17.95B | −$386.2M | ||||||||
| NetflixCOMMON STOCK · shares −9.1% · price +32.5% | 4.0% | $14.73B | +$3.62B | ||||||||
| AmazonCOMMON STOCK · shares −16% · price +17.4% | 3.2% | $11.62B | +$1.73B | ||||||||
| MicrosoftCOMMON STOCK · shares +2.7% · price +8.0% | 2.8% | $10.19B | +$738.5M | ||||||||
| Amgen IncCOMMON STOCK · shares −2.3% · price +8.3% | 2.3% | $8.48B | +$648.2M | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares +16% · price +1.8% | 2.2% | $8.00B | +$121.0M | ||||||||
| AlphabetCOMMON STOCK · shares +5.1% · price +8.1% | 2.0% | $7.20B | +$514.5M | ||||||||
| MetaCOMMON STOCK · shares +138% · price +21.6% | 1.9% | $6.83B | +$509.7M | ||||||||
| Eog Resources IncCOMMON STOCK · shares +17% · price +18.2% | 1.7% | $6.39B | +$838.8M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −15% · price +5.2% | 1.7% | $6.07B | +$300.2M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares +8.9% · price +14.6% | 1.6% | $6.01B | +$705.5M | ||||||||
| AlphabetCOMMON STOCK · shares +2.1% · price +8.9% | 1.6% | $5.83B | +$465.8M | ||||||||
| IntelCOMMON STOCK · shares −1.7% · price −4.6% | 1.6% | $5.69B | −$271.4M | ||||||||
| BroadcomCOMMON STOCK · shares +29% · price +3.0% | 1.5% | $5.36B | +$120.0M | ||||||||
| Csx CorpCOMMON STOCK · shares −17% · price +14.5% | 1.3% | $4.70B | +$594.5M | ||||||||
| Exxon Mobil CorpCOMMON STOCK · shares +33% · price +10.9% | 1.2% | $4.47B | +$329.6M | ||||||||
| Altria Group IncCOMMON STOCK · shares +36% · price −8.9% | 1.2% | $4.46B | −$318.6M | ||||||||
| General Dynamics CorpCOMMON STOCK · shares +16% · price −15.6% | 1.2% | $4.40B | −$700.1M | ||||||||
| Wells Fargo And CoCOMMON STOCK · shares +0.3% · price +5.8% | 1.2% | $4.33B | +$236.0M | ||||||||
| Nike Inc Cl BCOMMON STOCK · shares +1.1% · price +19.9% | 1.2% | $4.30B | +$707.3M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares −4.5% · price +6.6% | 1.2% | $4.27B | +$263.4M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +33% · price −6.0% | 1.1% | $4.04B | −$195.4M | ||||||||
| Stryker CorpCOMMON STOCK · shares −20% · price +4.9% | 1.1% | $3.98B | +$187.0M | ||||||||
| Home Depot IncCOMMON STOCK · shares −3.2% · price +9.5% | 1.1% | $3.86B | +$334.0M | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares −1.2% · price +0.3% | 1.1% | $3.86B | +$12.7M | ||||||||
| Total · 440 positions | 100% | $366.12B | +$14.64B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2018 to Q2 2018: 400 stocks held throughout, up $14.64B (+4.6%).
- Netflix+$3.62B+33%
- Amazon+$1.73B+17%
- Teva Pharmaceutical Industries Ltd ADR+$879.7M+42%
- Eog Resources Inc+$838.8M+18%
- Microsoft+$738.5M+8%
- Lockheed Martin Corp−$334.2M−13%
- Abbvie Inc−$386.2M−2%
- Herbalife Nutrition Ltd−$477.8M−45%
- General Dynamics Corp−$700.1M−16%
- Philip Morris International−$779.4M−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |